• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Aptar Pharma

FDA approves first nasally administered pharmaceutical treatment for dry eye

October 25, 2021 By Sean Whooley

AptarGroup (NYSE:ATR) announced today that it received FDA approval for its nasal pump to deliver a pharmaceutical treatment for dry eye. Crystal Lake, Illinois–based Aptar said the patented Cartridge Pump System (CPS) is for the multidose delivery of preserved and non-preserved drug formulations. It has received approval as the device for delivering Oyster Point Pharma’s Tyrvaya […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Optical/Ophthalmic, Pharmaceutical, Regulatory/Compliance Tagged With: Aptar Pharma, AptarGroup, FDA, Oyster Point Pharma

Aptar applies for EUA for N95 decontamination process

April 6, 2020 By Sean Whooley

Aptar announced that it is seeking FDA emergency use authorization (EUA) for its N95 mask decontamination process with ActivShield. The N95 masks (produced by Honeywell (NYSE:HON) and 3M (NYSE:MMM)) are in short supply and high demand during the COVID-19 pandemic. To disinfect the masks, a small strip of Aptar’s ActivShield is placed alongside an N95 mask inside a […]

Filed Under: Food & Drug Administration (FDA), Hospital Care, Regulatory/Compliance, Respiratory Tagged With: Aptar Pharma, Battelle, coronavirus, COVID-19

Aptar wins FDA clearance for ready-to-use seizure treatment device

December 9, 2019 By Danielle Kirsh

AptarGroup today said it won FDA approval for its Unidose Liquid System that treats acute repetitive seizures in people who have epilepsy. The Unidose Liquid System is a device that delivers a nasal rescue treatment that is ready-to-use when and where a seizure cluster occurs. Get the full story on our sister site, Drug Delivery Business […]

Filed Under: Drug-Device Combinations Tagged With: Aptar Pharma, Epilepsy

Aptar Pharma’s two-dose nasal spray device to deliver epinephrine

October 21, 2019 By Nancy Crotti

Aptar Pharma has entered an agreement for Bryn Pharma to use Aptar’s Bidose (BDS) nasal device to deliver Bryn’s epinephrine nasal spray (BRYN-NDS1C). Crystal Lake, Ill.-based Aptar’s Bidose tech enables two-shot nasal drug delivery and will replace the need to carry two epinephrine auto-injectors, according to the companies. Last March, Aptar won FDA approval to use Bidose for a […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Aptar Pharma, Bryn Pharma, FDA

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS